Barriers to Cancer Screening Among Orthodox Jewish Women
Overview
Authors
Affiliations
The increased risk of genetic cancer mutations for Ashkenazi Jews is well known. However, little is known about the cancer-related health behaviors of a subset of Ashkenazi Jews, Orthodox Jews, who are a very religious and insular group. This study partnered with Rabbinical leadership and community members in an Orthodox Jewish community to investigate barriers to cancer screening in this community. Orthodox Jewish women were recruited to participate in focus groups designed to elicit their perspectives on barriers to cancer screening. A total of five focus groups were conducted, consisting of 3-5 members per group, stratified by age and family history of cancer. Focus groups were audio recorded and transcribed. Transcripts were coded using conventional content analysis. The resulting themes identified as barriers to cancer screening were: preservation of hidden miracles, fate, cost, competing priorities, lack of culturally relevant programming, lack of information, and fear. These results provide a unique perspective on barriers to cancer screening in a high risk but understudied population. Findings from this study may serve to inform culturally appropriate cancer education programs to overcome barriers to screening in this and other similar communities.
Religious Disaffiliates' Experiences and Challenges with Sex, Sexuality, and Body Image.
Orr Z, Zalcman B, Romem A, Pinchas-Mizrachi R Arch Sex Behav. 2024; 54(1):205-219.
PMID: 39167333 DOI: 10.1007/s10508-024-02961-y.
Miller A, Aisenbrey S, Kimmel D J Relig Health. 2022; 61(6):4398-4419.
PMID: 35913643 DOI: 10.1007/s10943-022-01623-4.
Religiosity Level and Mammography Performance Among Arab and Jewish Women in Israel.
Pinchas-Mizrachi R, Solnica A, Daoud N J Relig Health. 2020; 60(3):1877-1894.
PMID: 33123970 DOI: 10.1007/s10943-020-01097-2.
Public perception of predictive cancer genetic testing and research in Oregon.
Alvord T, Marriott L, Nguyen P, Shafer A, Brown K, Stoller W J Genet Couns. 2020; 29(2):259-281.
PMID: 32220044 PMC: 7466847. DOI: 10.1002/jgc4.1262.
Stangl A, Earnshaw V, Logie C, van Brakel W, Simbayi L, Barre I BMC Med. 2019; 17(1):31.
PMID: 30764826 PMC: 6376797. DOI: 10.1186/s12916-019-1271-3.